drugset / Trial / NCT02458118

Pancreatic Perfusion Using Secretin and MRI

NCT02458118

Phase 1/2 Unknown 15 enrolled University of Nottingham
NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of this study is to assess pancreatic perfusion in patients with chronic pancreatitis at rest and after secretin stimulation and compare this to published data on pancreatic perfusion in normal subjects.

Timeline

Start
2012-06
Primary completion
2016-04
Completion
2016-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Background Secretin Other / unclassified 1 iu/kg

Indications